Delivery Order SPE2DB20D1110-SPE2DB24FK10E
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,436.94 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of MICARDIS HCT 80-25 MG TABLET UD 30S, a pharmaceutical product, with a completion date of February 6, 2024. This delivery order contract is issued under a larger, single-award indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,037.76 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award and does not have any major subcontractors identified. This delivery order is part of a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide MICARDIS HCT 80-25 mg tablet prescriptions. The contract, valued at $1,294.00, has a performance period through March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,790.77 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of MICARDIS HCT 80-25 MG TABLET UD 30S, with a performance period through January 30, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,037.48 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MICARDIS HCT 80-25 MG TABLET UD 30S. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Micardis HCT 80-25 mg tablet units. The contract has a ceiling value of $12,617.56 and runs through November 2, 2022. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $1,556.64 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical division. The award is for the supply of Micardis HCT 80-25 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,720.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets, with a performance period through April 4, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,489.28 by the Defense Logistics Agency Medical Supply Chain on August 11, 2025, for the supply of Micardis HCT 80-12.5 mg tablet unit dose packaging (30 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $1,459.71 firm fixed price delivery order is for the supply of MICARDIS HCT 40-12.5 MG TABLET UD 30S, a brand name pharmaceutical product. The contract has an ultimate completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB24FK10EDelivery Order
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,591.37 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Micardis HCT 80-12.5 mg tablets, a pharmaceutical product. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation associated with this award. Additionally, AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA with a potential value of $999,999,999.00 through December 31, 2025. This larger contract vehicle serves as the primary means for AmerisourceBergen to deliver a comprehensive range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 4/8/24 |